Stock market announcement archive

Lifecare ASA: Ex. consolidation (reverse split) of shares and warrants today

October 1, 2024
Reference is made to the stock exchange announcement made on 27 September 2024 with key information regarding the consolidation (reverse split) of the Company’s shares and the warrants issued by the Company pursuant to a resolution made by the extraordinary general meeting held on 16 May 2024 (the “Warrants”). The following information is provided in […]
Read more

Lifecare ASA: Share consolidation (reverse split) and change of par value

September 30, 2024
Reference is made to the extraordinary general meeting in Lifecare ASA (the “Company”) held on 17 September 2024, where it was resolved to carry out a share consolidation (reverse split) in the ratio of 13:1. The share consolidation has now been registered with the Norwegian Register of Business Enterprises, and the Company’s share capital is […]
Read more

Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants and change of ISIN for the shares

September 27, 2024
Reference is made to the extraordinary general meeting of the Company held on 17 September 2024, where it was resolved to consolidate the Company’s shares. Reference is further made to the warrants issued by the Company pursuant to a resolution by the extraordinary general meeting of the Company held on 16 May 2024 (the “Warrants”). […]
Read more

Lifecare ASA: Re-purchase of shares and warrants completed

September 25, 2024
Reference is made to the stock exchange announcement made by Lifecare ASA (the “Company”) earlier today, 25 September 2024, regarding the re-purchase by the Company of up to 30,000 shares and up to 7,500 warrants in the Company in connection with the contemplated 13:1 consolidation of the Company’s shares and warrants. The Company has now […]
Read more

Lifecare ASA: Re-purchase of shares and warrants

September 25, 2024
Reference is made to the contemplated consolidation of shares in Lifecare ASA (the “Company”) in a ratio of 13:1, as resolved by the extraordinary general meeting of the Company held on 17 September 2024. Reference is further made to the 54,519,478 warrants (the “Warrants”) issued by the Company pursuant to resolutions made by the extraordinary […]
Read more

Minutes from Extraordinary General Meeting

September 17, 2024
The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 17 September 2024. All proposals on the agenda were adopted, cf. the notification of the Extraordinary General Meeting that was published on Oslo Stock Exchange on 3 September 2024. The complete minutes of the Extraordinary General Meeting are attached and will […]
Read more

LIFECARE ASA: Extraordinary General Meeting

September 3, 2024
Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), will hold an Extraordinary General Meeting 17 September 2024, at 09:00 (CEST). For the planned uplisting from Euronext Growth Oslo to Oslo Børs, a share consolidation is required to meet the NOK 10 per share listing requirement. Additionally, to […]
Read more

Correction: LIFE: Lifecare ASA Q2 2024

August 30, 2024
Reference is made to the Q2 2024 report published by Lifecare ASA (the “Company”) on 27 August 2024. In connection with the uplisting to Euronext Oslo Børs, the Company has conducted new assessments of its financial statements and, in collaboration with its auditor, concluded to recognize the warrants issued in connection with the previously announced […]
Read more

LIFE: Lifecare ASA Q2 2024

August 27, 2024
Bergen, Norway, 27 August 2024: Today, Lifecare ASA (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q2 financial report and operational update. In the second quarter Lifecare continued to build positive momentum towards automatic production by delivering milestones on a continuous basis over a long […]
Read more